100% Quality Guarantee
PhD-Level Technical Support
Human CD85j/LILRB1/ILT2 (BND-22) Antibody - SDS-PAGE
Key Features

Human CD85j/LILRB1/ILT2 (BND-22) Antibody (GXBS01458)

SKU GXBS01458
Product Type Research Grade Biosimilar
Antibody Type Monoclonal
Host Species Mouse
Reactivity Human
Applications ELISA, FCM, Functional assay, Research in vivo
Clone ID BND-22
Isotype IgG2a, kappa
€513 - €1,673

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human CD85j/LILRB1/ILT2 (BND-22) Antibody

Human CD85j/LILRB1/ILT2 (BND-22) Antibody is a research-grade biosimilar monoclonal antibody targeting CD85. It is a mouse IgG2a, kappa antibody. Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.

Leukocyte immunoglobulin-like receptor subfamily B member 1 (CD85j/LILRB1) is a ~70 kDa protein. Receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. Receptor for H301/UL18, a human cytomegalovirus class I MHC homolog. Ligand binding results in inhibitory signals and down-regulation of the immune response. Engagement of LILRB1 present on natural killer cells or T-cells by class I MHC molecules protects the target cells from lysis.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose